[1] SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. [2] 夏伟安, 王伟伟, 周楠楠, 等. 红细胞分布宽度和同型半胱氨酸在胃癌诊断中的临床意义[J]. 皖南医学院学报, 2022, 41(4):365-368. [3] 郑潇豪, 解亦斌. 中国晚期胃癌的诊疗现状[J]. 癌症进展, 2019, 17(1):13-19, 48. [4] 王婷, 禹蓉, 董卫国.胃癌肝转移不良预后的独立危险因素研究进展[J]. 中国临床医生杂志, 2022, 50(1):33-36. [5] 姚强, 金俊, 邓建良, 等. 胃癌肝转移患者预后影响因素分析[J]. 肿瘤学杂志, 2018, 24(2):104-108. [6] 许雅洁, 龙泉河, 杜文涛, 等. 胃癌肝转移患者预后列线图的建立与危险分层[J]. 医学研究杂志, 2022, 51(9):122-127. [7] 侯松林, 谢兴江, 彭强, 等. 基于SEER数据库的胃癌肝转移预后因素分析与预后模型构建[J]. 中国普通外科杂志, 2020, 29(10):1212-1223. [8] OKI E, TOKUNAGA S, EMI Y, et al. Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302)[J]. Gastric Cancer, 2016, 19(3):968-976. [9] HUONG P T, NGUYEN L T, NGUYEN X B, et al. The role of platelets in the tumor-microenvironment and the drug resistance of cancer cells[J]. Cancers: Basel, 2019, 11(2):240. [10] 莫珍珍, 丁娟娟, 周林华, 等. 血细胞参数及ANCA在川崎病早期诊断中的研究[J]. 皖南医学院学报, 2022, 41(6):558-560, 568. [11] HAEMMERLE M, STONE R L, MENTER D G, et al. The platelet lifeline to cancer: challenges and opportunities[J]. Cancer Cell, 2018, 33(6):965-983. [12] ROMANO F, UGGERI F, CRIPPA S, et al. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers [J]. J Exp Clin Cancer Res, 2004, 23(2):195-200. [13] LIN W F, ZHONG M F, ZHANG Y R, et al. Prognostic role of platelet-to-lymphocyte ratio in hepatocellular carcinoma with different BCLC stages: a systematic review and meta-analysis[J]. Gastroenterol Res Pract, 2018, 2018:5670949. [14] 刘倩倩, 杨卫华. 系统免疫-炎性反应指数与小细胞肺癌脑转移患者预后的关系[J]. 肿瘤, 2019, 39(8):649-657. [15] 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1):38-44. [16] 王盼. NLR、PLR、GGT、ALBI对肝细胞癌患者预后判断价值的比较[D]. 南宁:广西医科大学, 2018. [17] 任书勤, 章阳. 肝癌患者血清γ-GT、GLB、ALB、CHOL及AFP水平变化及其临床意义[J]. 标记免疫分析与临床, 2020, 27(3):398-404. [18] HAYASHI K, NAHASAKI E, NAKADA K, et al. Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2[J]. J Infect Chemother, 2018, 24(4):298-301. [19] CHIEN M H, KU C C, JOHANSSON G, et al. Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway[J]. Carcinogenesis, 2009, 30(12):2005-2013. [20] 卢先东, 时国兵. 肝动脉介入化疗栓塞术后甲胎蛋白的应答对进展期肝癌预后的影响[J]. 肝脏, 2018, 23(8):689-692. [21] 丁平安, 杨沛刚, 田园, 等. 血清甲胎蛋白阳性胃癌患者的临床病理学特征及预后分析[J]. 中国癌症杂志, 2020, 30(11):887-896. |